Actively Recruiting
Led by AstraZeneca · Updated on 2026-05-14
744
Participants Needed
303
Research Sites
104 weeks
Total Duration
A
AstraZeneca
Lead Sponsor
D
Daiichi Sankyo
Collaborating Sponsor
Researchers are evaluating the effects of Dato-DXd combined with osimertinib or Dato-DXd alone compared to platinum-based doublet chemotherapy in people with EGFR-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC) whose disease progressed after prior osimertinib treatment. This Phase III, open-label, randomized study aims to compare progression-free survival among these treatments to better understand options for this condition. Participants are randomly assigned to one of three groups: Dato-DXd plus osimertinib, Dato-DXd alone, or platinum-based doublet chemotherapy. Dato-DXd is given as an intravenous infusion every 3 weeks, osimertinib is taken orally daily, and chemotherapy involves pemetrexed combined with carboplatin or cisplatin every 3 weeks for four cycles, followed by maintenance pemetrexed. Treatments continue until disease progression, unacceptable side effects, or other reasons to stop. Throughout the study, participants undergo regular assessments including radiological scans to monitor tumor response using RECIST v1.1 criteria, safety evaluations, and health status measurements. After stopping treatment, an end-of-treatment visit occurs within 35 days, followed by safety follow-up 28 days after the last dose. The study primarily measures progression-free survival over up to 2.5 years, with additional outcomes including overall survival, response rates, quality of life, and pharmacokinetics monitored for up to 3.5 years.
CONDITIONS
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Until radiological progression or discontinuation
Participants receive assigned study treatment until disease progression, unacceptable toxicity, or other discontinuation criteria are met.
Infusions every 3 weeks; daily oral medication for osimertinib group
Duration - 28 days after last dose
Participants are monitored for safety after treatment discontinuation.
1 follow-up visit within 35 days of treatment end and safety assessments up to 28 days post last dose
Total: 303 locations
1
Research Site
Fayetteville, Arkansas, United States, 72703
Actively Recruiting
2
Research Site
Duarte, California, United States, 91010
Withdrawn
3
Research Site
Fountain Valley, California, United States, 92708
Actively Recruiting
4
Research Site
La Jolla, California, United States, 92093
Actively Recruiting
5
Research Site
Los Angeles, California, United States, 90048
Withdrawn
6
Research Site
San Diego, California, United States, 92123
Actively Recruiting
7
Research Site
Colorado Springs, Colorado, United States, 80909
Actively Recruiting
8
Research Site
Fort Collins, Colorado, United States, 80528
Actively Recruiting
9
Research Site
Washington D.C., District of Columbia, United States, 20007
Not Yet Recruiting
10
Research Site
Gainesville, Florida, United States, 32608
Withdrawn
11
Research Site
Jacksonville, Florida, United States, 32256
Actively Recruiting
12
Research Site
Athens, Georgia, United States, 30607
Actively Recruiting
13
Research Site
Chicago, Illinois, United States, 60611
Actively Recruiting
14
Research Site
Evanston, Illinois, United States, 60201
Actively Recruiting
15
Research Site
Louisville, Kentucky, United States, 40207
Actively Recruiting
16
Research Site
Baltimore, Maryland, United States, 21201
Actively Recruiting
17
Research Site
Bethesda, Maryland, United States, 20817
Actively Recruiting
18
Research Site
Boston, Massachusetts, United States, 02114
Withdrawn
19
Research Site
Boston, Massachusetts, United States, 02215
Actively Recruiting
20
Research Site
Detroit, Michigan, United States, 48202
Actively Recruiting
21
Research Site
Kansas City, Missouri, United States, 64132
Actively Recruiting
22
Research Site
Omaha, Nebraska, United States, 68124
Actively Recruiting
23
Research Site
Morristown, New Jersey, United States, 07960
Actively Recruiting
24
Research Site
Northfield, New Jersey, United States, 08225
Actively Recruiting
25
Research Site
New York, New York, United States, 10016
Withdrawn
26
Research Site
New York, New York, United States, 10065
Actively Recruiting
27
Research Site
The Bronx, New York, United States, 10461
Actively Recruiting
28
Research Site
Maumee, Ohio, United States, 43537
Actively Recruiting
29
Research Site
Philadelphia, Pennsylvania, United States, 19107
Withdrawn
30
Research Site
Pittsburgh, Pennsylvania, United States, 15232
Actively Recruiting
31
Research Site
Chattanooga, Tennessee, United States, 37404
Actively Recruiting
32
Research Site
Nashville, Tennessee, United States, 37203
Actively Recruiting
33
Research Site
Fairfax, Virginia, United States, 22031
Actively Recruiting
34
Research Site
Seattle, Washington, United States, 98104
Withdrawn
35
Research Site
Fitzroy, Australia, VIC3065
Actively Recruiting
36
Research Site
Heidelberg, Australia, 3084
Actively Recruiting
37
Research Site
Kogarah, Australia, 2217
Actively Recruiting
38
Research Site
Liverpool, Australia, 2170
Actively Recruiting
39
Research Site
Nedlands, Australia, 6009
Actively Recruiting
40
Research Site
Port Macquarie, Australia, 2444
Actively Recruiting
41
Research Site
St Leonards, Australia, 2065
Actively Recruiting
42
Research Site
Westmead, Australia, 2145
Actively Recruiting
43
Research Site
Woodville, Australia, 5011
Withdrawn
44
Research Site
Woolloongabba, Australia, 4102
Actively Recruiting
45
Research Site
Charleroi, Belgium, 6060
Actively Recruiting
46
Research Site
Edegem, Belgium, 2650
Actively Recruiting
47
Research Site
Ghent, Belgium, 9000
Actively Recruiting
48
Research Site
Hasselt, Belgium, 3500
Actively Recruiting
49
Research Site
Jette, Belgium, 1090
Actively Recruiting
50
Research Site
La Louvière, Belgium, 7100
Actively Recruiting
51
Research Site
Leuven, Belgium, 3000
Actively Recruiting
52
Research Site
Namur, Belgium, 5000
Actively Recruiting
53
Research Site
Roeselare, Belgium, 8800
Actively Recruiting
54
Research Site
Barretos, Brazil, 14784-400
Actively Recruiting
55
Research Site
Betim, Brazil, 32671-550
Actively Recruiting
56
Research Site
Blumenau, Brazil, 89010-340
Actively Recruiting
57
Research Site
Florianópolis, Brazil, 88040-970
Actively Recruiting
58
Research Site
Itajaí, Brazil, 88301-220
Actively Recruiting
59
Research Site
Pelotas, Brazil, 96020-080
Actively Recruiting
60
Research Site
Porto Alegre, Brazil, 90035-074
Actively Recruiting
61
Research Site
Porto Alegre, Brazil, 90470-340
Actively Recruiting
62
Research Site
Porto Alegre, Brazil, 90610-000
Actively Recruiting
63
Research Site
Rio de Janeiro, Brazil, 22250-905
Actively Recruiting
64
Research Site
Rio de Janeiro, Brazil, 22281-100
Actively Recruiting
65
Research Site
Rio de Janeiro, Brazil, 22775-001
Actively Recruiting
66
Research Site
São Paulo, Brazil, 01323-900
Withdrawn
67
Research Site
São Paulo, Brazil, 01327-001
Actively Recruiting
68
Research Site
Brampton, Ontario, Canada, L6R 3J7
Actively Recruiting
69
Research Site
Newmarket, Ontario, Canada, L3Y 2P9
Withdrawn
70
Research Site
Toronto, Ontario, Canada, M4N 3M5
Actively Recruiting
71
Research Site
Toronto, Ontario, Canada, M5G 1Z5
Actively Recruiting
72
Research Site
Montreal, Quebec, Canada, H4A 3J1
Actively Recruiting
73
Research Site
Québec, Quebec, Canada, G1R 2J6
Actively Recruiting
74
Research Site
Baoding, China, 071000
Actively Recruiting
75
Research Site
Beijing, China, 100005
Actively Recruiting
76
Research Site
Beijing, China, 100034
Actively Recruiting
77
Research Site
Beijing, China, 100044
Actively Recruiting
78
Research Site
Beijing, China, 100050
Actively Recruiting
79
Research Site
Beijing, China, 100142
Actively Recruiting
80
Research Site
Beijing, China, 100730
Actively Recruiting
81
Research Site
Beijing, China, 101199
Actively Recruiting
82
Research Site
Bengbu, China, 233004
Actively Recruiting
83
Research Site
Changchun, China, 130012
Actively Recruiting
84
Research Site
Changchun, China, 130021
Actively Recruiting
85
Research Site
Changsha, China, 410013
Actively Recruiting
86
Research Site
Chengdu, China, 610041
Actively Recruiting
87
Research Site
Deyang, China, 618000
Actively Recruiting
88
Research Site
Ganzhou, China, 341099
Actively Recruiting
89
Research Site
Guangzhou, China, 510180
Actively Recruiting
90
Research Site
Hangzhou, China, 310003
Actively Recruiting
91
Research Site
Hangzhou, China, 310022
Actively Recruiting
92
Research Site
Hefei, China, 230001
Actively Recruiting
93
Research Site
Hengyang, China, 421001
Actively Recruiting
94
Research Site
Huaian, China, 223399
Actively Recruiting
95
Research Site
Jinan, China, 250013
Actively Recruiting
96
Research Site
Linyi, China, 276000
Actively Recruiting
97
Research Site
Luoyang, China, 471003
Actively Recruiting
98
Research Site
Luzhou, China, 646000
Actively Recruiting
99
Research Site
Nanchang, China, 330006
Actively Recruiting
100
Research Site
Nanjing, China, 210009
Actively Recruiting
101
Research Site
Shanghai, China, 200433
Actively Recruiting
102
Research Site
Shantou, China
Actively Recruiting
103
Research Site
Shenyang, China, 110004
Actively Recruiting
104
Research Site
Shenyang, China, 110042
Actively Recruiting
105
Research Site
Tianjin, China, 300201
Actively Recruiting
106
Research Site
Tianjin, China, CN-300052
Actively Recruiting
107
Research Site
Weifang, China, 261000
Actively Recruiting
108
Research Site
Wuhan, China, 430060
Actively Recruiting
109
Research Site
Zhengzhou, China, 450000
Actively Recruiting
110
Research Site
Zhengzhou, China, 450001
Actively Recruiting
111
Research Site
Zhengzhou, China, 450008
Actively Recruiting
112
Research Site
Angers, France, 49933
Actively Recruiting
113
Research Site
Avignon, France, 84902
Actively Recruiting
114
Research Site
Bordeaux, France, 33076
Actively Recruiting
115
Research Site
Caen, France, 14000
Actively Recruiting
116
Research Site
Lille, France, 59037
Actively Recruiting
117
Research Site
Montpellier, France, 34298
Actively Recruiting
118
Research Site
Nantes, France, 44093
Actively Recruiting
119
Research Site
Paris, France, 75014
Actively Recruiting
120
Research Site
Paris, France, 75970
Actively Recruiting
121
Research Site
Pessac, France, 33604
Actively Recruiting
122
Research Site
Quimper, France, 29000
Withdrawn
123
Research Site
Toulon Armees, France, 83800
Actively Recruiting
124
Research Site
Toulouse, France, 31400
Actively Recruiting
125
Research Site
Tours, France, 37000
Actively Recruiting
126
Research Site
Villejuif, France, 94805
Actively Recruiting
127
Research Site
Berlin, Germany, 12351
Actively Recruiting
128
Research Site
Berlin-Zehlendorf, Germany, 14165
Actively Recruiting
129
Research Site
Bonn, Germany, 53127
Withdrawn
130
Research Site
Essen, Germany, 45122
Actively Recruiting
131
Research Site
Georgsmarienhütte, Germany, 49124
Actively Recruiting
132
Research Site
Giessen, Germany, 35392
Actively Recruiting
133
Research Site
Großhansdorf, Germany, 22927
Actively Recruiting
134
Research Site
Hamburg, Germany, 20251
Actively Recruiting
135
Research Site
Hamburg, Germany, 21075
Actively Recruiting
136
Research Site
Heidelberg, Germany, 69126
Withdrawn
137
Research Site
Kempten, Germany, 87439
Withdrawn
138
Research Site
Löwenstein, Germany, 74245
Actively Recruiting
139
Research Site
Nuremberg, Germany, 90419
Actively Recruiting
140
Research Site
Oldenburg, Germany, 26121
Actively Recruiting
141
Research Site
Athens, Greece, 11526
Actively Recruiting
142
Research Site
Athens, Greece, 11527
Actively Recruiting
143
Research Site
Athens, Greece, 12462
Withdrawn
144
Research Site
Athens, Greece, 18547
Actively Recruiting
145
Research Site
Heraklion, Greece, 71110
Withdrawn
146
Research Site
Thessaloniki, Greece, 552 36
Actively Recruiting
147
Research Site
Thessaloniki, Greece, 56249
Withdrawn
148
Research Site
Thessaloniki, Greece, 57001
Actively Recruiting
149
Research Site
Thessaloniki, Greece, 57010
Actively Recruiting
150
Research Site
Hong Kong, Hong Kong, 999077
Actively Recruiting
151
Research Site
Hong Kong, Hong Kong, 999077
Withdrawn
152
Research Site
Hong Kong, Hong Kong
Actively Recruiting
153
Research Site
Hong Kong, Hong Kong
Withdrawn
154
Research Site
Shatin, Hong Kong, 00000
Actively Recruiting
155
Research Site
Amravati, India, 444606
Actively Recruiting
156
Research Site
Bhubaneswar, India, 751019
Actively Recruiting
157
Research Site
Hyderabad, India, 500034
Actively Recruiting
158
Research Site
Kolhāpur, India, 416234
Actively Recruiting
159
Research Site
Mumbai, India, 400012
Not Yet Recruiting
160
Research Site
Mysuru, India, 570017
Actively Recruiting
161
Research Site
Namakkal, India, 637001
Actively Recruiting
162
Research Site
Pune, India, 411001
Actively Recruiting
163
Research Site
Raipur, India, 492001
Actively Recruiting
164
Research Site
Rajasthan, India, 313001
Actively Recruiting
165
Research Site
Ranchi, India, 834001
Actively Recruiting
166
Research Site
Thane, India, 401107
Actively Recruiting
167
Research Site
Trivandrum, India, 695011
Actively Recruiting
168
Research Site
Varanasi, India, 221005
Actively Recruiting
169
Research Site
Beersheba, Israel, 8410101
Actively Recruiting
170
Research Site
Haifa, Israel, 3109601
Actively Recruiting
171
Research Site
Haifa, Israel, 34362
Actively Recruiting
172
Research Site
Jerusalem, Israel, 91031
Actively Recruiting
173
Research Site
Jerusalem, Israel, 91120
Actively Recruiting
174
Research Site
Kfar Saba, Israel, 4428164
Actively Recruiting
175
Research Site
Petah Tikva, Israel, 49100
Actively Recruiting
176
Research Site
Ramat Gan, Israel, 52621
Actively Recruiting
177
Research Site
Tel Aviv, Israel, 62748
Actively Recruiting
178
Research Site
Bari, Italy, 70124
Actively Recruiting
179
Research Site
Milan, Italy, 20141
Actively Recruiting
180
Research Site
Misterbianco, Italy, 95045
Actively Recruiting
181
Research Site
Monza, Italy, 20090
Actively Recruiting
182
Research Site
Naples, Italy, 80131
Actively Recruiting
183
Research Site
Orbassano, Italy, 10043
Actively Recruiting
184
Research Site
Padova, Italy, 35128
Actively Recruiting
185
Research Site
Parma, Italy, 43126
Withdrawn
186
Research Site
Perugia, Italy, 06100
Actively Recruiting
187
Research Site
Roma, Italy, 00144
Actively Recruiting
188
Research Site
Rozzano, Italy, 20089
Actively Recruiting
189
Research Site
Verona, Italy, 37126
Actively Recruiting
190
Research Site
Bunkyō City, Japan, 113-8431
Actively Recruiting
191
Research Site
Bunkyō City, Japan, 113-8603
Actively Recruiting
192
Research Site
Fukuoka, Japan, 812-8582
Actively Recruiting
193
Research Site
Hiroshima, Japan, 734-8551
Actively Recruiting
194
Research Site
Iruma-Gun, Japan, 350-0495
Actively Recruiting
195
Research Site
Iwakuni-shi, Japan, 740-8510
Actively Recruiting
196
Research Site
Kobe, Japan, 650-0046
Actively Recruiting
197
Research Site
Kōtoku, Japan, 135-8550
Actively Recruiting
198
Research Site
Kumamoto, Japan, 860-8556
Actively Recruiting
199
Research Site
Kyoto, Japan, 602-8566
Actively Recruiting
200
Research Site
Matsuyama, Japan, 791-0280
Actively Recruiting
201
Research Site
Nagoya, Japan, 464-8681
Withdrawn
202
Research Site
Nagoya, Japan, 466-8560
Actively Recruiting
203
Research Site
Niigata, Japan, 951-8566
Actively Recruiting
204
Research Site
Osaka, Japan, 534-0021
Actively Recruiting
205
Research Site
Osaka, Japan, 541-8567
Actively Recruiting
206
Research Site
Ōsaka-sayama, Japan, 589-8511
Actively Recruiting
207
Research Site
Sendai, Japan, 981-0914
Actively Recruiting
208
Research Site
Sunto-gun, Japan, 411-8777
Actively Recruiting
209
Research Site
Toyoake-shi, Japan, 470-1192
Actively Recruiting
210
Research Site
Utsunomiya, Japan, 320-0834
Actively Recruiting
211
Research Site
Wakayama, Japan, 641-8510
Actively Recruiting
212
Research Site
Yokohama, Japan, 236-0051
Actively Recruiting
213
Research Site
Yokohama, Japan, 241-8515
Actively Recruiting
214
Research Site
Alor Star, Malaysia, 05460
Actively Recruiting
215
Research Site
Cheras, Malaysia, 56000
Actively Recruiting
216
Research Site
Johor Bahru, Malaysia, 81100
Actively Recruiting
217
Research Site
Kuala Lumpur, Malaysia, 59100
Actively Recruiting
218
Research Site
Kuala Selangor, Malaysia, 46050
Actively Recruiting
219
Research Site
Kuching, Malaysia, 93586
Actively Recruiting
220
Research Site
Perai, Malaysia, 13700
Actively Recruiting
221
Research Site
Petaling Jaya, Malaysia, 47500
Actively Recruiting
222
Research Site
Amersfoort, Netherlands, 3813 TZ
Withdrawn
223
Research Site
Amsterdam, Netherlands, 1066CX
Withdrawn
224
Research Site
Harderwijk, Netherlands, 3844 DG
Withdrawn
225
Research Site
Rotterdam, Netherlands, 3015 GD
Withdrawn
226
Research Site
Zutphen, Netherlands, 7207 AE
Withdrawn
227
Research Site
Bacolod, Philippines, 6100
Actively Recruiting
228
Research Site
Cebu City, Philippines, 6000
Actively Recruiting
229
Research Site
Davao City, Philippines, 8000
Actively Recruiting
230
Research Site
Manila, Philippines, 1000
Actively Recruiting
231
Research Site
Quezon, Philippines, 1102
Actively Recruiting
232
Research Site
Quezon, Philippines, 1104
Actively Recruiting
233
Research Site
San Juan City, Philippines, 1500
Actively Recruiting
234
Research Site
Katowice, Poland, 40-519
Actively Recruiting
235
Research Site
Krakow, Poland, 30-727
Actively Recruiting
236
Research Site
Lodz, Poland, 90-302
Actively Recruiting
237
Research Site
Olsztyn, Poland, 10-357
Actively Recruiting
238
Research Site
Poznan, Poland, 60-569
Actively Recruiting
239
Research Site
Braga, Portugal, 4710
Withdrawn
240
Research Site
Lisbon, Portugal, 1500-650
Withdrawn
241
Research Site
Loures, Portugal, 2674-514
Withdrawn
242
Research Site
Porto, Portugal, 4099-001
Withdrawn
243
Research Site
Porto, Portugal, 4200-072
Withdrawn
244
Research Site
Craiova, Romania, 200385
Withdrawn
245
Research Site
Craiova, Romania, 200542
Withdrawn
246
Research Site
Singapore, Singapore, 168583
Actively Recruiting
247
Research Site
Singapore, Singapore, 217562
Actively Recruiting
248
Research Site
Singapore, Singapore, 308433
Actively Recruiting
249
Research Site
Busan, South Korea, 48108
Actively Recruiting
250
Research Site
Chungcheongbuk-do, South Korea, 28644
Actively Recruiting
251
Research Site
Goyang-si, South Korea, 10408
Actively Recruiting
252
Research Site
Gyeonggi-do, South Korea, 13620
Actively Recruiting
253
Research Site
Jinju, South Korea, 52727
Withdrawn
254
Research Site
Seoul, South Korea, 03080
Actively Recruiting
255
Research Site
Seoul, South Korea, 03722
Actively Recruiting
256
Research Site
Seoul, South Korea, 06351
Actively Recruiting
257
Research Site
Seoul, South Korea, 06591
Actively Recruiting
258
Research Site
Seoul, South Korea, 5505
Actively Recruiting
259
Research Site
Suwon, South Korea, 16247
Actively Recruiting
260
Research Site
A Coruña, Spain, 15009
Actively Recruiting
261
Research Site
Barakaldo, Spain, 48903
Actively Recruiting
262
Research Site
Barcelona, Spain, 08003
Actively Recruiting
263
Research Site
Barcelona, Spain, 08041
Actively Recruiting
264
Research Site
El Palmar, Spain, 30120
Actively Recruiting
265
Research Site
L'Hospitalet de Llobregat, Spain, 08908
Actively Recruiting
266
Research Site
Madrid, Spain, 28027
Actively Recruiting
267
Research Site
Madrid, Spain, 28046
Actively Recruiting
268
Research Site
Majadahonda, Spain, 28222
Actively Recruiting
269
Research Site
Málaga, Spain, 29004
Actively Recruiting
270
Research Site
Oviedo, Spain, 33006
Actively Recruiting
271
Research Site
Palma de Mallorca, Spain, 7120
Actively Recruiting
272
Research Site
Pamplona, Spain, 31008
Actively Recruiting
273
Research Site
Santander, Spain, 39008
Actively Recruiting
274
Research Site
Santiago de Compostela-Coruña, Spain, 15706
Actively Recruiting
275
Research Site
Seville, Spain, 41014
Actively Recruiting
276
Research Site
Valencia, Spain, 46010
Actively Recruiting
277
Research Site
Valencia, Spain, 46026
Actively Recruiting
278
Research Site
Valladolid, Spain, 47003
Actively Recruiting
279
Research Site
Changhua, Taiwan, 50006
Actively Recruiting
280
Research Site
Kaohsiung City, Taiwan, 80756
Actively Recruiting
281
Research Site
New Taipei City, Taiwan, 23561
Actively Recruiting
282
Research Site
Taichung, Taiwan, 404
Actively Recruiting
283
Research Site
Taichung, Taiwan, 40705
Actively Recruiting
284
Research Site
Tainan, Taiwan, 70403
Actively Recruiting
285
Research Site
Tainan, Taiwan, 73657
Actively Recruiting
286
Research Site
Taipei, Taiwan, 100
Actively Recruiting
287
Research Site
Taipei, Taiwan, 110
Actively Recruiting
288
Research Site
Taipei, Taiwan, 112
Actively Recruiting
289
Research Site
Bangkok, Thailand, 10330
Actively Recruiting
290
Research Site
Bangkok, Thailand, 10400
Actively Recruiting
291
Research Site
Bangkok, Thailand, 10700
Actively Recruiting
292
Research Site
Chiang Mai, Thailand, 50200
Actively Recruiting
293
Research Site
Hat Yai, Thailand, 90110
Actively Recruiting
294
Research Site
Khon Kaen, Thailand, 40002
Actively Recruiting
295
Research Site
Pathum Thani, Thailand, 12120
Actively Recruiting
296
Research Site
Birmingham, United Kingdom, B9 5SS
Actively Recruiting
297
Research Site
Cambridge, United Kingdom, CB2 0QQ
Actively Recruiting
298
Research Site
Glasgow, United Kingdom, G12 0YN
Actively Recruiting
299
Research Site
Leicester, United Kingdom, LE1 5WW
Actively Recruiting
300
Research Site
London, United Kingdom, EC1A 7BE
Actively Recruiting
301
Research Site
Manchester, United Kingdom, M20 4BX
Actively Recruiting
302
Research Site
Middlesbrough, United Kingdom, TS4 3BW
Actively Recruiting
303
Research Site
Hanoi, Vietnam, 100000
Actively Recruiting
A
AstraZeneca Clinical Study Information Center
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Daniel Shao-Weng Tan, Ernest Nadal, Parneet Cheema...
https://pubmed.ncbi.nlm.nih.gov/41466843